Real‑world assessment: effectiveness and safety of extended‑release calcifediol and other vitamin D therapies for secondary hyperparathyroidism in CKD patients
Germain MJ, Paul SK, Fadda G, Broumand V, Nguyen A, µgarvey NH, Gitlin MD, Bishop CW, Csomor P, Strugnell S, Ashfaq A. Real-world assessment: effectiveness and safety of extended-release calcifediol and other vitamin D therapies for secondary hyperparathyroidism in CKD patients. BMC Nephrol, 2022. 11;23(1):362. doi: 10.1186/s12882-022-02993-3.
Abstrak
(Konten ini khusus untuk dokter. Registrasi untuk baca selengkapnya)